AP Insights, News, Videos, and More

After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...

A study from the University of Texas at Arlington backs previous research that shows women are more likely than men to develop an addiction to cocaine, try cocaine at a younger age, use larger amounts of the drug, and suffer an overdose.

A recent meta-analysis of 10 longitudinal studies conducted by Yale University researchers found no significant link between cannabis use and relapse on non-medical opioids among patients receiving medication-assisted treatment for opioid use...

Allegheny Health Network seeks 2 additional patients for a trial in which patients with treatment-resistant opioid use disorder receive continuous electrical pulses to the brain’s addiction and reward center to curb severe cravings.

The Centers for Medicare & Medicaid Services have introduced a new initiative aimed at advancing the integration of behavioral and physical healthcare, as well as health-related social needs, for people with Medicaid and Medicare.

Findings from a recent study conducted by researchers at the Medical University of South Carolina suggest that N-acetylcysteine (NAC)—a drug already approved by the US Food and Drug Administration—may help decrease surgery patients’ pain...

Reducing use of stimulants was associated with significant improvement in health and recovery among individuals with stimulant use disorder—even if they did not achieve total abstinence, according to a new study from NIDA.

New research from Oregon Health & Science University highlights challenges related to finding residential addiction treatment for adolescents, with medication-assisted treatment options especially scarce.

The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.

While prescribing of opioid-containing pain relief medications for surgery patients has declined over the past 7 years, a recent study of pharmacy data by researchers at the University of Michigan shows that decrease has slowed since 2020.